Fundraising plan launched by Housing Development Finance Corporation (HDFC) is boosting investor confidence
Shares of India’s biggest mortgage lender jumped by 1.5% in early morning trade after the company announced that it has plans to raise Rs 14,000 crore through its new equity fundraising program.
Around Rs 10000 crs will come from qualified institutional placement (QIP) and Rs 4000 crs in warrants.
The floor price for the equity shares has been set to Rs 1,838.94 and the board of directors will meet again on August 10 to determine the issue price.
In addition to the Rs 14,000 crore, HDFC will also be issuing secured redeemable non-convertible debentures worth Rs 9,000 crore.
This is the third time in the last 12 years that HDFC is raising capital through such an offering. It did so once in 2009 and then again in 2015.
HDFC’s first full quarter in the face of the coronavirus pandemic saw a loss of 4.7% at the end of June. Its gross non-performing loans stood at Rs 8,631 crore accounting for 1.87% of HDFC’s loan portfolio.
It already has Rs 12,285 in the bank as provisions to serve as a cushion once the Reserve Bank of India’s (RBI) moratorium ends on August 31. It even added another Rs 1,199 this quarter specifically for COVID related accounts.
Despite having safeguards in place, many companies are going down the QIP route to shore up capital against the uncertainty of the coronavirus pandemic.
This includes Kotak Mahindra Bank, Info Edge and — most recently to lay down its offering — Axis Bank for a whopping Rs 10,000 crore. Others either have approved fundraising plans on stand by or are in the process of putting out their own QIP.
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.